Clinical Trials Browser

Recruiting × olaparib × Tumor-Agnostic × Clear all

NCT04585958 2026-03-17

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Phase 1 Recruiting

Neoplasm Metastasis

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT02029001 2025-08-07

MOST plus

Phase 2 Recruiting

Neoplasm Metastasis